Martingale Asset Management »

Arbutus Biopharma shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $927k 193k 4.80

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp (XOM)
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Two Seas Capital
State Street Corporation
Rubric Capital Management
Vanguard Capital Management
Barclays
Geode Capital Management
Goldman Sachs Group
Bank of America Corporation
BlackBarn Capital Partners
Legal & General Group
Woodline Partners
Leucadia National Corporation
Nomura Holdings

View all funds holding Arbutus Biopharma